Health Condition 1: N209- Urinary calculus, unspecified
Conditions
Interventions
None listed
Sponsors
Pushpanjali Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stone disease. Patients undergoing unilateral stenting.
Exclusion criteria
Exclusion criteria: Patients with any neurological condition Patients with urinary tract malignancy Patients with congenital urinary tract abnormality Patients with comorbid urologic anatomical abnormalities, such as ureteral stricture Pregnant or lactating females Patients with known psychiatric illness Patients who refused consent to participate in study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the prevalence and bother of various urinary tract symptoms caused by indwelling ureteral stents using validated questionnaireTimepoint: Patients symptoms will be assessed at time of stent removal approximately 4 weeks after endourological procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall incidence of various stent related symptoms in patients undergoing endourological treatment for stone disease. Comparison of incidence of stent related symptoms with respect to different stent materials used. Comparison of incidence of stent related symptoms with respect to different sizes of the stent used. Impact of duration of stent, medication used and various other factors on ureteral stent related symptoms.Timepoint: Outcomes will be assessed after the removal of stent | — |
Countries
India
Contacts
Public ContactAnurag Yadav
Pushpanjali Hospital
Outcome results
None listed